Literature DB >> 7565415

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

A Roulston1, R Lin, P Beauparlant, M A Wainberg, J Hiscott.   

Abstract

CD4+ macrophages in tissues such as lung, skin, and lymph nodes, promyelocytic cells in bone marrow, and peripheral blood monocytes serve as important targets and reservoirs for human immunodeficiency virus type 1 (HIV-1) replication. HIV-1-infected myeloid cells are often diminished in their ability to participate in chemotaxis, phagocytosis, and intracellular killing. HIV-1 infection of myeloid cells can lead to the expression of surface receptors associated with cellular activation and/or differentiation that increase the responsiveness of these cells to cytokines secreted by neighboring cells as well as to bacteria or other pathogens. Enhancement of HIV-1 replication is related in part to increased DNA-binding activity of cellular transcription factors such as NF-kappa B. NF-kappa B binds to the HIV-1 enhancer region of the long terminal repeat and contributes to the inducibility of HIV-1 gene expression in response to multiple activating agents. Phosphorylation and degradation of the cytoplasmic inhibitor I kappa B alpha are crucial regulatory events in the activation of NF-kappa B DNA-binding activity. Both N- and C-terminal residues of I kappa B alpha are required for inducer-mediated degradation. Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication. Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B-dependent cytokine gene expression. In response to secondary pathogenic infections or antigenic challenge, cytokine gene expression is rapidly induced, enhanced, and sustained over prolonged periods in HIV-1-infected myeloid cells compared with uninfected cells. Elevated levels of several inflammatory cytokines have been detected in the sera of HIV-1-infected individuals. Secretion of myeloid cell-derived cytokines may both increase virus production and contribute to AIDS-associated disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565415      PMCID: PMC239370          DOI: 10.1128/mr.59.3.481-505.1995

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  412 in total

1.  Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters.

Authors:  M J Tevethia; D J Spector; K M Leisure; M F Stinski
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

2.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

Authors:  M Siekevitz; S F Josephs; M Dukovich; N Peffer; F Wong-Staal; W C Greene
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

4.  The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites.

Authors:  B R Franza; F J Rauscher; S F Josephs; T Curran
Journal:  Science       Date:  1988-03-04       Impact factor: 47.728

5.  Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

Authors:  J G Haas; G Riethmüller; H W Ziegler-Heitbrock
Journal:  Scand J Immunol       Date:  1987-10       Impact factor: 3.487

Review 6.  Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).

Authors:  S Roy; M A Wainberg
Journal:  J Leukoc Biol       Date:  1988-01       Impact factor: 4.962

7.  An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.

Authors:  S Kenney; J Kamine; D Markovitz; R Fenrick; J Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease.

Authors:  J M Andrieu; P Even; A Venet; J M Tourani; M Stern; W Lowenstein; C Audroin; D Eme; D Masson; H Sors
Journal:  Clin Immunol Immunopathol       Date:  1988-05

9.  Activation of human immunodeficiency virus type 1 by DNA damage in human cells.

Authors:  K Valerie; A Delers; C Bruck; C Thiriart; H Rosenberg; C Debouck; M Rosenberg
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

10.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  56 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 2.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages.

Authors:  Wonkyu Choe; David J Volsky; Mary Jane Potash
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 4.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 5.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

6.  Phagocytic function of monocytes in children with human immunodeficiency virus type 1 infection.

Authors:  G Tardei; D Duiculescu; C Capo; C C Diaconu; A Mutiu; J L Mege; C E Cernescu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

7.  Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.

Authors:  Ann Florence B Victoriano; Kaori Asamitsu; Yurina Hibi; Kenichi Imai; Nina G Barzaga; Takashi Okamoto
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  NF-κB Activation Promotes Alphavirus Replication in Mature Neurons.

Authors:  Jane X Yeh; Eunhye Park; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 9.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

10.  Variability in drug metabolizing enzyme activity in HIV-infected patients.

Authors:  Amanda E Jones; Kevin C Brown; Rebecca E Werner; Karl Gotzkowsky; Andrea Gaedigk; Mike Blake; David W Hein; Charles van der Horst; Angela D M Kashuba
Journal:  Eur J Clin Pharmacol       Date:  2010-01-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.